AVTE Share Price Performance
US$93.80
2.98 (3.28%)
Price US$93.80
Share Pricen/a
Aerovate Therapeutics, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
AVTE Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Aerovate Therapeutics, Inc. Key Details
About AVTE
- Founded
- 2018
- Employees
- 4
- CEO
- WebsiteView website
Aerovate Therapeutics, Inc., a biopharmaceutical company, engages in the treatment of pulmonary arterial hypertension in the United States. Aerovate Therapeutics, Inc., was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
